Insider · CIK 0001435618
Martin Babler
Files at PRLD (Prelude Therapeutics Inc), ETNB (89bio, Inc.), ALMS (ALUMIS INC.). First filing Apr 3, 2025, latest Apr 3, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ALMS: ALUMIS INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 54Moderate | ALUMIS INC. | $101k 15,650 shares | +17% | +103% from low-44% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 29, 2025 | ALMS ALUMIS INC. | AGrant or award Stock Option (Right to Buy)derivative | +662,000 | $0.00 | $0 | 662,000 | Jul 31, 2025 |
| Jul 29, 2025 | ALMS ALUMIS INC. | AGrant or award Stock Option (Right to Buy)derivative | +150,000 | $0.00 | $0 | 150,000 | Jul 31, 2025 |
| Jun 12, 2025 | PRLD Prelude Therapeutics Inc | AGrant or award Director Stock Option (Right to Buy)derivative | +38,000 | $0.00 | $0 | 38,000 | Jun 13, 2025 |
| Apr 1, 2025 | ALMS ALUMIS INC. | POpen-market purchase Common Stockindirect: By Trust | +15,650 | $6.44 | $101k | 106,454 | Apr 3, 2025 |
| Feb 18, 2025 | ALMS ALUMIS INC. | AGrant or award Stock Option (Right to Buy)derivative | +523,000 | $0.00 | $0 | 523,000 | Feb 20, 2025 |
| Feb 3, 2025 | ETNB 89bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +56,400 | $0.00 | $0 | 56,400 | Feb 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.